Repetitive Transcranial Magnetic Stimulation
Not Applicable
Completed
- Conditions
- Schizophrenia
- Registration Number
- NCT00169689
- Lead Sponsor
- Heinrich-Heine University, Duesseldorf
- Brief Summary
The study is a prospective, randomized, double-blind sham-controlled study.
- Detailed Description
The principal objective of this trial is to investigate the effect of left prefrontal high frequency rTMS on negative symptoms in schizophrenia.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- DSM-IV criteria for schizophrenia
- age between 18 and 60
- informed consent
- right handed patient
- no change of antipsychotic treatment > 2 weeks before recruitment
Exclusion Criteria
- seizures, epilepsy
- history of severe head injury
- status post implantation of a cardiac pacemaker or other electronic devi-ses
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Clinical Global Impression; November 2007
- Secondary Outcome Measures
Name Time Method Global psychosocial functioning (GAF), PANSS-Negative Subscale,changes in EEG, heart rate variability, cortisol daytime profile, catecholamines, cognitive functioning November 2007
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the therapeutic effects of high-frequency rTMS on negative symptoms in schizophrenia?
How does high-frequency rTMS compare to antipsychotic medications in managing negative symptoms of schizophrenia?
Are there specific biomarkers that predict response to left prefrontal rTMS in schizophrenia patients with negative symptoms?
What are the potential adverse events associated with high-frequency rTMS in schizophrenia treatment and how are they managed?
What combination therapies or alternative interventions have been explored alongside rTMS for treating negative symptoms in schizophrenia?
Trial Locations
- Locations (1)
Joachim Cordes
🇩🇪Düsseldorf, Rhineland, Germany
Joachim Cordes🇩🇪Düsseldorf, Rhineland, Germany